Salute e Benessere

Amphista Therapeutics discloses first details of its TEAD Targeted Glue™ program…

Amphista Therapeutics discloses first details of its TEAD Targeted Glue™ program and unveils new mechanism of action for TEAD degradation via FBXO22First disclosure of a novel mechanism of action for the degradation of TEAD by selectively inducing its proximity to FBXO22 as a targeted molecular glue, leading to strong and rapid degradation of TEAD.Structurally-guided discovery using high-resolution cryo-EM has delivered TEAD Targeted Glues™ with exceptional potency.Firstin vivo...

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October…

MAINZ, Germany, September 23, 2025 (GLOBE NEWSWIRE)-- BioNTech SE(Nasdaq: BNTX, “BioNTech”), alongside its artificial intelligence (“AI”) companyInstaDeep Ltd.(“InstaDeep”), will host its second AI Day, an edition of BioNTech’s “Innovation Series”, at 09:00 a.m. EDT (3:00 p.m. CEST) on Wednesday, October 1, 2025, in London, United Kingdom. The event will provide an overview of BioNTech’s AI strategy and capabilities, and the application of AI in BioNTech’s pipeline and internal...

Desenio unveils exclusive collections with home stylists Arvin Olvano, Reserve…

Each stylist worked together with Desenio over several months to create unique collections that allow fans and followers to have a little something from each stylist in their home. Arvin's collection is inspired by vintage art, Mallory's by artist's sketchbooks, while Saraa's collection sparks joy and colour. Each stylist worked together with Desenio over several months to create unique collections that allow fans and followers to have a little something from each stylist in their home...

AI in Oncology For Analytical Solutions Market Size & Share to Surpass $8.86…

This growth reflects the rising adoption of AI-driven tools for early detection, tumor subtyping, therapy selection, and real-world outcomes analytics. With the global cancer burden increasing, these solutions are enabling faster, more accurate clinical decisions while reducing costs and improving patient outcomes. This growth reflects the rising adoption of AI-driven tools for early detection, tumor subtyping, therapy selection, and real-world outcomes analytics. With the global cancer…

JOYROOM Launches the PR1 Retractable Power Bank: An Innovative Blend of Power…

Pocket-sized Power: Sleek, Compact and Ready to GoWeighing only 200g, the JR-PR1 slips easily into any pocket or bag. With 22.5W fast charging, it keeps devices running through commutes, workdays, and leisure moments. Pairing seamlessly with the new iPhone 17 series, it redefines pocket-sized power with style. Pocket-sized Power: Sleek, Compact and Ready to GoWeighing only 200g, the JR-PR1 slips easily into any pocket or bag. With 22.5W fast charging, it keeps devices running through...

Mindray Unveils Project 2030 and Re-writes the Future of Women's Health…

During the congress, Prof. Savino Gil Pugliese (Head of Fetal Surgery, University Hospital of Córdoba) and Prof. Roberto Albinagorta (ISUOG Ambassador to Latin America) delivered the scan demo session, steering the Mindray Nuewa R9 Platinum through first-trimester fetal hearts and complex gynecologic masses. Crystal-clear 4D, super-resolution color and smart quantification drew spontaneous applause from hundreds of delegates. "This is a new grammar for ultrasound storytelling,"…

Economist Impact's 5th edition Future of Health Asia returns to Singapore amid…

SINGAPORE, Sept. 23, 2025 /PRNewswire/ -- Convening on October 16th at the Four Seasons Hotel, the5th edition Future of Health Asiawill bring together 500 senior leaders from healthcare, government and patient advocacy to examine the impact of rising technological disruptions, rising pressure of chronic diseases and global economic uncertainty. SINGAPORE , Sept. 23, 2025 /PRNewswire/ -- Convening onOctober 16that the Four Seasons Hotel, the 5th edition Future of Health Asia will...

Santhera Announces Half Year 2025 Financial Results and Provides Corporate…

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 23, 2025, at 14:00 CEST / 13:00 BST / 08:00 EDT.Details are at the end of this news releasePratteln, Switzerland, September 23, 2025–Santhera Pharmaceuticals (SIX: SANN) announces the Company’s financial results for the six months ended June 30, 2025, reports on progress with AGAMREE® (vamorolone) for the treatment of Duchenne muscular dystrophy (DMD) and provides updates on its corporate and...

Sweden, the world's first travel destination on prescription

Watch how experiences in Sweden can boost health: www.youtube.com/watch?v=hqo3PZwOZhk Watchhow experiences inSwedencan boost health :www.youtube.com/watch?v=hqo3PZwOZhk The new survey conducted by YouGov revealed that most respondents had not heard about nature, social or culture prescriptions by doctors. But nearly two out of three would be open to following them. "Nature, social settings and culture have restorative powers, and evidently,Swedenhas these assets in...

Invitation to presentation of Essity's interim report for quarter 3, 2025

Contact information for conference call with the possibility to ask questions:UK: +44 (0) 33 0551 02 00 USA: +1 786 697 35 01SWE: +46 (0)8 505 204 24Please call in well in advance of the start of the presentation. Indicate: "Essity". Contact information for conference call with the possibility to ask questions: UK: +44 (0) 33 0551 02 00 USA : +1 786 697 35 01 SWE: +46 (0)8 505 204 24 Please call in well in advance of the start of the presentation. Indicate…

SciBase receives initial order for clinical study from Castle Biosciences

Following the signing of the collaboration agreement, Castle has also invested in SciBase and is now SciBase second largest shareholder. Following the signing of the collaboration agreement, Castle has also invested in SciBase and is now SciBase second largest shareholder. "The collaboration with Castle Biosciences is moving forward at a fast pace and this first order signals the initiation of our first joint study," said Pia Renaudin , CEO of SciBase. "At SciBase we are very…

PioCreat Debuts PioNext Mini Dental 3D Printer at 2025 Moscow Dental Expo

The PioNext Mini is an ultra-compact, suitcase-style dental 3D printer (200 × 170 × 230 mm) that saves space and integrates curing in one device, making it easy to carry and ideal for chairside use. Designed for speed and efficiency, it produces crowns in just 10 minutes, while other common chairside applications can be completed within 30 minutes, all with ultra-high resolution for precise, aesthetic results. With the optional LD resin vat, clinicians can achieve smooth, high-translucency…

Santhera Announces Half Year 2025 Financial Results and Provides Corporate…

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 23, 2025, at 14:00 CEST / 13:00 BST / 08:00 BST.Details are at the end of this news releasePratteln, Switzerland, September 23, 2025–Santhera Pharmaceuticals (SIX: SANN) announces the Company’s financial results for the six months ended June 30, 2025, reports on progress with AGAMREE® (vamorolone) for the treatment of Duchenne muscular dystrophy (DMD) and provides updates on its corporate and...

Press Release: Sanofi’s SAR446268 earns US fast track designation for the…

Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1Designation earned for one-time AAV gene therapy SAR446268, designed to silence DMPK expressionMyotonic dystrophy type 1 (DM1) is a rare, genetic disorder that causes progressive muscle weakness and wasting, with no currently approved medicinesParis, September 23, 2025. The US Food and Drug Administration (FDA) has granted fast track designation to SAR446268, Sanofi's...

Santhera Secures CHF 20 Million Growth Funding to Accelerate Global AGAMREE®…

Ad hoc announcement pursuant to Art. 53 LR Highlights:Santhera secures approximately CHF 20 million of additional funding from existing investors Highbridge and R-Bridge to accelerate global rolloutDemand for AGAMREE® (vamorolone) in US/China ahead of plan; increased inventory needs and launch timing shifts drive need for incremental growth capitalPratteln, Switzerland, September 23, 2025 –Santhera Pharmaceuticals (SIX: SANN) today announces new financing agreements with...

Addex Appoints Bank of New York Mellon as Depositary Bank

Ad Hoc Announcement Pursuant to Art. 53 LRGeneva, Switzerland, September 23, 2025-Addex Therapeutics(SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced the appointment the Bank of New-York Mellon (BNY) as its new ADS depositary agent. This change is expected to become effective on October 6, 2025. The appointment of BNY has no impact on the...

Neuromod Advance Multiple Regulatory Approvals to Expedite Global Availability…

Following MDSAP certification Neuromod secured both Health Canada and TGA approval to place Lenire on the market in those territories. Following MDSAP certification Neuromod secured both Health Canada and TGA approval to place Lenire on the market in those territories. Tinnitus, which is commonly known as ringing in the ears, is a complex neurological condition that affects 15% of the global adult population 1. "Neuromod's commitment to delivering the highest quality of patient care...

With Millions of Children's Lives on the Line, Bill Gates Says Humanity Is at a…

Honors President of the Government of Spain with 2025 Global Goalkeeper Award and 10 champions for their ingenuity and resilience, and for offering hope, solutions in the face of steep funding cuts Honors President of the Government ofSpainwith 2025 Global Goalkeeper Award and 10 champions for their ingenuity and resilience, and for offering hope, solutions in the face of steep funding cuts NEW YORK , Sept. 222025/PRNewswire/ -- At its 2025 Goalkeepers event, Gates Foundation...

Prurigo Nodularis market to exhibit growth at a CAGR of 23.2% (2020-2034)…

Key Takeaways from the Prurigo Nodularis Market Report Key Takeaways from the Prurigo Nodularis Market Report Discover which therapies are expected to grab the major prurigo nodularis treatment market share @Prurigo Nodularis Market Report Key Factors Driving the Prurigo Nodularis Market Rising Prurigo Nodularis Disease Prevalence and Awareness The increasing prevalence of prurigo nodularis, particularly among individuals with underlying skin conditions like atopic...

GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update

Cash and cash equivalents totaled €107.5 million as of June 30, 2025, excluding the €26.5 million milestone invoiced in May 2025 (received in July 2025) upon pricing and reimbursement approval of Iqirvo® (elafibranor) in three major European countries€33.5 million in revenues, including the €26.5 million milestone invoiced in May 2025Strong 1H25 sales trajectory reported by Ipsen for Iqirvo® in PBC in July, followed by U.S. market exit of key competitor in SeptemberFollowing...

IBA – Transparency Notification

(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)Louvain-la-Neuve (Belgium), 22 September 2025, 06:00 PM Summary of the notificationIBA (Ion Beam Applications S.A - EURONEXT - Reuters IBAB.BR - Bloomberg IBAB.BB), the world leader in particle accelerator technology, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further...

Guerbet : Change in General Management

Change in General ManagementVillepinte France, September 22nd, 2025: Guerbet(FR0000032526 GBT),a global specialist in contrast agents and solutions for medical imaging, announces the appointment of Mr. Jérôme Estampes as interim Chief Executive Officer. Jérôme Estampes replaces Mr. David Hale, who is leaving the Group to pursue new projects. The Board of Directors thanks him for his work since joining Guerbet in February 2018, initially as Chief Commercial Officer and then as...

Lab Automation Market is Projected To Reach US$8.71 Billion By 2031 at CAGR of…

Check valuable insights in the Lab Automation Market report. You can easily get a sample PDF of the report -https://www.theinsightpartners.com/sample/TIPHE100001249/ Check valuable insights in the Lab Automation Market report. You can easily get a sample PDF of the report -https://www.theinsightpartners.com/sample/TIPHE100001249/ Overview of Report Findings 1. Market Dynamics and Insights:Laboratories are under pressure to improve operational efficiency while remaining...

Parkinson's Disease Therapeutics Market Size to Hit US$ 12.83 Billion by 2033…

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/parkinsons-disease-therapeutics-market Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/parkinsons-disease-therapeutics-market Parkinson's NSW calls Parkinson's disease an emerging pandemic, with global cases doubling from 1990 to 2015 to over 6.2 million, and...

Altri Comunicati